Alkermes Submits Supplemental New Drug Application for VIVITROL for the Treatment of Opioid Dependence

Posted on by

More info…
WALTHAM, Mass.—-Alkermes, Inc. today announced that it has submitted a supplemental New Drug Application for VIVITROL to the U.S. Food and Drug Administration for approval as a treatment for opioid dependence.

drug addictions rehab

Share and Enjoy:
  • Digg
  • del.icio.us
  • Facebook
  • NewsVine
  • Reddit
  • StumbleUpon
  • YahooMyWeb
  • Google Bookmarks
  • Yahoo! Buzz
  • TwitThis
  • Live
  • LinkedIn
  • Pownce
  • MySpace

Leave a Reply

Your email address will not be published. Required fields are marked *

*

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>

Security Code: